Who owns EWTX? 13F holders and whale ownership
EWTX is tracked across public portfolios in Whale Analyzer. This page answers who owns EWTX, which top funds are buying EWTX, aggregate disclosed value, and recent position changes based on public data. Samuel Isaly is the largest reported holder at $489M; the top five funds control 100.0% of reported ownership; institutions were net selling last quarter (0 increased, 1 reduced); the stock trades above the aggregate whale cost basis of $18.71. Top tracked holders include Samuel Isaly, Peter Kolchinsky, Baker Bros. Advisors, and Joseph Edelman.
Continue to the live EWTX dashboardTop holders
| Investor | Reported value | Shares | Change |
|---|---|---|---|
| Samuel Isaly 13F portfolio OrbiMed Advisors holdings | $488.8M | 15.5M | Held |
| Peter Kolchinsky 13F portfolio RA Capital Management holdings | $328.5M | 10.4M | Held |
| Baker Bros. Advisors 13F portfolio Baker Bros. Advisors holdings | $207.1M | 6.6M | Held |
| Joseph Edelman 13F portfolio Perceptive Advisors holdings | $139.4M | 4.4M | Reduced |
Ownership concentration
Reported ownership of EWTX is highly concentrated across tracked institutions.
- Single largest holder: 42.0% of reported ownership
- Top 5 holders: 100.0%
- Top 10 holders: 100.0%
Whale activity this quarter
Across 4 tracked institutions, 3 held, 1 reduced. Net positioning is net selling.
- Samuel Isaly — OrbiMed Advisors ($488.8M) (→ 0.0% qoq shares) · avg cost $27.95
- Peter Kolchinsky — RA Capital Management ($328.5M) (→ 0.0% qoq shares) · avg cost $15.48
- Baker Bros. Advisors — Baker Bros. Advisors ($207.1M) (→ 0.0% qoq shares) · avg cost $9.03
- Joseph Edelman — Perceptive Advisors ($139.4M) (▼ 0.8% qoq shares) · avg cost $8.29
Whale cost basis vs current price
The aggregate tracked cost basis is $18.71 versus a current price of $41.46, so EWTX trades above its cost basis (+121.6%). Average unrealized P&L across tracked holders: 172%.
Sector positioning — Health Care
EWTX sits within the Health Care sector alongside 221 other tracked names. Compare whale ownership across peers:
How to use this page
Values are reported public positions from tracked 13F filers and disclosures — not real-time ownership totals. Open the live EWTX dashboard for price charts and cross-investor scans, or read the SEC 13F guide.
Related stock holder pages
- ELVN whale holders — ENLIVEN THERAPEUTICS INC
- LLY whale holders — ELI LILLY & CO
- SVA whale holders — SINOVAC BIOTECH LTD
- BSX whale holders — BOSTON SCIENTIFIC CORP
- SION whale holders — SIONNA THERAPEUTICS INC
- AZN whale holders — ASTRAZENECA PLC
- MYGN whale holders — MYRIAD GENETICS INC
- MBX whale holders — MBX BIOSCIENCES INC
Learn more in Whale Analyzer Academy
Deepen your read on EWTX with these Whale Analyzer Academy guides:
Frequently asked questions
Who owns EWTX stock?
Whale Analyzer tracks 4 public institutional holders of EWTX with a combined reported value of $1.16B. See the holder table above for the largest tracked positions.
Which top funds are buying EWTX?
Tracked institutions were net selling last quarter — 3 held, 1 reduced. Check the "Change" column: "New" = fresh position, "Increased" = added, "Reduced" = trimmed.
How concentrated is EWTX ownership?
The top five tracked holders report 100.0% of aggregate ownership.
Is EWTX above or below the whale cost basis?
The aggregate tracked cost basis is $18.71 versus a current price of $41.46 (+121.6%).
What does 13F ownership mean for EWTX?
Use the interactive EWTX dashboard on Whale Analyzer for real-time holder analysis, or read our 13F Alpha Signals Guide.